Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)

The Federal Circuit reversed a District Court grant of judgment as a matter of law (JMOL) that overturned a jury verdict that defendant Eli Lilly had not satisfied the clear-and-convincing-evidence standard in challenging on Section 112(a) grounds claims asserted by Teva Pharmaceuticals in Teva Pharmaceuticals International v. Eli Lilly & Co. In addition to providing a “man bites dog” aspect to the case, the opinion also sets forth...... By: McDonnell Boehnen Hulbert & Berghoff LLP